Related Experiment Video
Updated: May 5, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
Gemcitabine-induced thrombotic microangiopathy
1Cancer and Palliative Care Services, Toowoomba Health Service, Toowoomba, Queensland, Australia.
Abstract:
Thrombotic microangiopathy (TMA) is a microvascular occlusive disorder characterised by platelet aggregation, thrombocytopenia and end-organ damage. It is commonly idiopathic, although several drug classes, including cytotoxic chemotherapy, have been implicated. Several of cases of gemcitabine-induced TMA have been documented with incidence likely to increase with the escalating use of gemcitabine. We report the cases of two patients who developed TMA while on gemcitabine chemotherapy.
Related Concept Videos
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
Cytomegalovirus Disease
